g-Nostics

About:

G-Nostics develops diagnostic treatments and tests for individuals undergoing drug rehabilitation.

Top Investors: Oxford Capital, GEIF Ventures

Description:

g-Nostics Ltd. provides research in molecular profiling to predict individual response to drug therapy. g-Nostics Ltd. is based in Didcot, United Kingdom. g-Nostics Ltd. is former subsidiary of Oxford University and Cancer Research UK.